Neoplasms by Site Clinical Trials
79 clinical trials for Neoplasms by Site across international registries, including 16 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
- Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer — RECRUITING · PHASE1
- HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors — RECRUITING · PHASE1
- Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer — RECRUITING · PHASE3
- DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers. — RECRUITING · PHASE2
- DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations — RECRUITING · PHASE2
- DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers — RECRUITING · PHASE2
- DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition — RECRUITING · PHASE2
- Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma — RECRUITING · PHASE1
- Early Intervention Strategies for Lung Cancer — RECRUITING · NA
- Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer. — RECRUITING · NA
- 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer — RECRUITING · PHASE4
- OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. — RECRUITING
- A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC — RECRUITING · PHASE2
- Spanish Series of Patients Treated With the Radionuclide Lutetium177 — RECRUITING
- Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients — RECRUITING · PHASE2
- A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations — ACTIVE_NOT_RECRUITING · PHASE1
- High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy — TERMINATED · PHASE2
- Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab — ACTIVE_NOT_RECRUITING · PHASE2
- Savolitinib vs. Sunitinib in MET-driven PRCC. — ACTIVE_NOT_RECRUITING · PHASE3
- Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study — ACTIVE_NOT_RECRUITING
- Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC — ACTIVE_NOT_RECRUITING
- Real World Registry for Use of the Ion Endoluminal System — ACTIVE_NOT_RECRUITING
- An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors — COMPLETED · PHASE1
- A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) — TERMINATED · PHASE3
- DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. — NOT_YET_RECRUITING · PHASE2
- Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies — COMPLETED · PHASE1
- Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma — ACTIVE_NOT_RECRUITING · NA
- Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLC — TERMINATED
- Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 — TERMINATED · PHASE1
- Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) — TERMINATED · PHASE2
- A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20) — COMPLETED · PHASE1
- Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy — COMPLETED · NA
- Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors — COMPLETED · PHASE1
- P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) — TERMINATED · PHASE1
- (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC — TERMINATED · PHASE1
- (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations — TERMINATED · PHASE1
- A Phase 1/2a Dose Escalation and Cohort Expansion Study of the Safety, Tolerability, and Efficacy of Anti-LAG-3 Monoclonal Antibody (BMS-986016) Administered Alone and in Combination with Anti-PD-1 Monoclonal Antibody (Nivolumab, BMS-936558) in Advanced Solid Tumors — OTHER · PHASE2
- CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL — COMPLETED · PHASE1
- The P10s-PADRE Basket Trial: Vaccination of Metastatic Cancer Patients — WITHDRAWN · PHASE2
- Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer — ACTIVE_NOT_RECRUITING · PHASE2
- Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer. — OTHER · NA
- A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts — OTHER · PHASE2
- EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC — OTHER · PHASE2
- International Lung Screen Trial (ILST) — OTHER · NA
- Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study — ACTIVE_NOT_RECRUITING · PHASE2
- Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial — COMPLETED · NA
- A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors — TERMINATED · PHASE2
- Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) — COMPLETED · PHASE3
- (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC — TERMINATED · PHASE1
Refine this search